Investigators found that CU06-1004, as a vascular leakage blocker, could improve cardiac function by inhibiting cardiac microvascular endothelial cells’ hyperpermeability and subsequently reducing the neutrophil’s plugging and infiltration in infarcted hearts.
[Experimental and Molecular Medicine]